Dhanuka Agritech is probably giving a breakout from a descending triangle chart pattern on the weekly charts. Read on to find out more.

Glenmark Pharmaceuticals announced on Tuesday that it has launched a fixed-dose combination (FDC) of its novel, patent-protected Sodium-Glucose co-transporter inhibitors (SGLT2i)- Remogliflozin Etabonate and another commonly used DPP4 inhibitor (Dipeptidyl Peptidase 4 inhibitor) – Vildagliptin, in India.  

Overall, a positive trend is observed in agritech stocks including Dhanuka Agritech. The company has nearly doubled since the beginning of 2020.  

Biocon Biologics Ltd (a subsidiary of Biocon Ltd) and Mylan (a subsidiary of Viatris Inc.) have been further informed by United States Food & Drug Administration (USFDA) regarding the deferral of the action on Biologics licence application (BLA) for MYL-1402O, a proposed biosimilar to Avastin® (Bevacizumab). 

As your child takes baby steps and gradually climbs his/her education ladder, you have ample time and option to plan the funding in advance via education loan or mutual fund investment. Read this to find out which one is better and why! 

The India International Exchange (IFSC) Limited (India INX) witnessed an all-time high trading turnover of over USD 13.05 billion which is of around Rs 96,033 crore.

BSE has signed a Memorandum of Understanding (MoU) with bullion trade and industry association Patliputra Sarafa Sangh, Patna, Bihar. 

Vaishali Pharma Ltd has hit the upper circuit after bagging its first bulk order worth Rs 16 crore for the delivery of PPE kits and other COVID-19 related medical kits. 

The launch of Tacrolimus capsules expands Biocon’s generic formulation portfolio in the US. 

On Monday, the stock had given a breakout above the neckline of a double bottom formation. This breakout is confirmed by the above 50-day average volume. Additionally, the stock had formed a sizeable bullish candle on the breakout day, which adds further strength to the breakout.